CHRISTOPHER DELLA ROCCA: Open Payments
NPI 1760995252 · WARRINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,150 in 63 payments from 17 companies in 2025. Trend: 2023 $1,508 · 2024 $1,740 · 2025 $1,150
Food & beverage: $1,150
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $188 |
| Novo Nordisk Inc | 10 | $184 |
| ABBVIE INC. | 12 | $174 |
| PFIZER INC. | 5 | $87 |
| GlaxoSmithKline, LLC. | 4 | $82 |
| Lilly USA, LLC | 4 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $74 |
| Exact Sciences Corporation | 3 | $54 |
| Inspire Medical Systems, Inc. | 2 | $54 |
| Merck Sharp & Dohme LLC | 2 | $37 |
Products named: AIRSUPRA, UBRELVY, MOUNJARO, JARDIANCE, SHINGRIX, INSPIRE, PAXLOVID, Wegovy.
Industry payments across PA — which companies pay providers there.
